• 1
    El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003; 139: 817823.
  • 2
    El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340: 745750.
  • 3
    Levrero M. Viral hepatitis and liver cancer: the case of hepatitis C. Oncogene 2006; 25: 38343847.
  • 4
    Lindenbach BD, Rice CM. Unravelling hepatitis C virus replication from genome to function. Nature 2005; 436: 933938.
  • 5
    Chang J, Yang SH CY, Hwang SB, Hahn YS, Sung YC. Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogene. J Virol 1998; 72: 30603065.
  • 6
    Ghosh A, Steele R, Meyer K, Ray R, Ray R. Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth. J Gen Virol 1999; 80: 11791183.
  • 7
    Ray R, Lagging L, Meyer K, Ray R. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol 1996; 70: 44384443.
  • 8
    Sakamuro D, Furukawa T, Takegami T. Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. J Virol 1995; 69: 38933896.
  • 9
    Park JS, Yang JM, Min MK. Hepatitis C virus nonstructural protein NS4B transforms NIH3T3 cells in cooperation with the Ha-ras oncogeneL: biochemical and biophysical research communications 2000; 267: 581587.
  • 10
    Einav S, Elazar M, Danieli T, Glenn JS. A nucleotide binding motif in hepatitis C virus (HCV) NS4B mediates HCV RNA replication. J Virol 2004; 78: 1128811295.
  • 11
    Gibbs J, Sigal I, Poe M, Scolnick E. Intrinsic GTPase activity distinguishes normal and oncogenic ras p21 molecules. Proc Natl Acad Sci U S A 1984; 81: 57045708.
  • 12
    Feig LA, Cooper GM. Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP: molecular and cellular biology 1988; 8: 32353243.
  • 13
    Blight KJ, Kolykhalov AA, Rice CM. Efficient initiation of HCV RNA replication in cell culture. Science 2000; 290: 19721974.
  • 14
    Shih C, Weinberg R. Isolation of a transforming sequence from a human bladder carcinoma cell line. Cell 1982; 29: 161169.
  • 15
    Clark GJ, Cox AD, Graham SM, Der CJ. Biological assays for Ras transformation. Methods Enzymol 1995; 255: 395412.
  • 16
    Quilliam LA, Kato K, Rabun KM, Hisaka MM, Huff SY, Campbell-Burk S, et al. Identification of residues critical for Ras(17N) growth-inhibitory phenotype and for Ras interaction with guanine nucleotide exchange factors. Mol Cell Biol 1994; 14: 11131121.
  • 17
    Bernstein SC, Weinberg RA. Expression of the metastatic phenotype in cells transfected with human metastatic tumor DNA. Proc Natl Acad Sci U S A 1985; 82: 17261730.
  • 18
    Sklan EH SK, Oakes TM, Elazar M, Winters M, Aroeti B, Danieli T, et al. A Rab-GAP TBC domain protein binds hepatitis C virus NS5A and mediates viral replication. J Virol 2007; 81: 1109611105.
  • 19
    Tomayko MM, Reynolds CP. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 1989; 24: 148154.
  • 20
    Lohmann V, Körner F, Koch J, Herian U, Theilmann L, Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999; 285: 110113.
  • 21
    Li W, Zhu T, Guan K-L. Transformation potential of Ras isoforms correlates with activation of phosphatidylinositol 3-kinase but not ERK. J Biol Chem 2004; 279: 3739837406.
  • 22
    Gimenez-Barcons M, Wang C, Chen M, Sanchez-Tapias J, Saiz J, Gale MJ. The oncogenic potential of hepatitis C virus NS5A sequence variants is associated with PKR regulation. J Interferon Cytokine Res 2005; 25: 152164.
  • 23
    Cho Y-G, J-W Yoon K-LJ, Kim C-M, Sung YC. Full genome cloning and nucleotide sequence analysis of hepatitis C virus from sera of chronic hepatitis patients in Korea. Mol Cells 1993; 3: 195202.
  • 24
    Valencia A, Kjeldgaard M, Pai E, Sander C. GTPase domains of ras p21 oncogene protein and elongation factor Tu: analysis of three-dimensional structures, sequence families, and functional sites. Proc Natl Acad Sci U S A 1991; 88: 54435447.
  • 25
    Jurnak F. Structure of the GDP domain of EF-Tu and location of the amino acids homologous to ras oncogene proteins. Science 1985; 230: 3236.
  • 26
    Block TM, Mehta AS, Fimmel CJ, Jordan R. Molecular viral oncology of hepatocellular carcinoma. Oncogene 2003; 22: 50935107.